Nebenwirkungen · Peyona (previously Nymusa)
Peyona 20 mg/mL solution for infusion and oral solution · Abschnitt 4.8 · PDF-Seite 6
HOS-121297 · Präparat HOS-095319
The known pharmacology and toxicology of caffeine and other methylxanthines predict the likely adverse reactions to caffeine citrate. Effects described include central nervous system (CNS) stimulation such as convulsion, irritability, restlessness and jitteriness, cardiac effects such as tachycardia, arrhythmia, hypertension and increased stroke volume, metabolism and nutrition disorders such as hyperglycaemia. These effects are dose related and may necessitate measurement of plasma levels and dose reduction.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2024-09-18T02:09:00Z · SHA-256 538bfaa1bbc4434dad321d044190ff4102a2e9d6bf1a8fbce0d4ca21d26015c6 · Passage 4adfb1312a5d9c48e5a30926bf11ab85e762d691fd8d8be8ef075060b213204a · Zeichen 31–545 im Abschnitt